Kevin Black

Professor of Psychiatry

Additional Titles & Roles


  • Professor of Neurology, of Radiology, and of Neuroscience

Education & Training


  • Fellowship, Movement Disorders and Neuroimaging: Washington University, St. Louis, MO, 1996
  • Residency: Washington University, St. Louis, MO, 1994
  • MD: Duke University, Durham, NC, 1990
  • BS, Mathematics: Brigham Young University, Provo, UT, 1986

Major Awards


  • Certification in Behavioral Neurology and Neuropsychiatry, United Council for Neurologic Subspecialties (UCNS), 2006, 2016
  • member, NIMH Motor Systems Domain RDoC workshop, 2016
  • Named a Fellow of CINP, the International College of Neuropsychopharmacology, 2015
  • Named a Fellow of the American Neuropsychiatric Association, 2006
  • Hope Award from the St. Louis chapter of the HDSA (Huntington Disease Society of America), 2006
  • American College of Neuropsychopharmacology (ACNP) / Bristol-Myers Squibb Travel Award, 2001

Areas of Clinical Interest


Tourette syndrome (TS) and other tic disorders, neuropsychiatry of Parkinson’s disease and dystonia, Huntington’s disease, tardive dyskinesia, catatonia, functional or atypical movement disorders

Research Interests


Tourette syndrome (TS) and other tic disorders.
Neuroimaging and clinical studies of TS and other movement disorders.
Neuroimaging methods development including pharmacological fMRI.
Methods development for analyzing results of deep brain stimulation (DBS).

Visit lab website

Key Publications


See more publications

Funded Research Projects


NIMH(Significant Contributor): Tourette Syndrome genetics and neuroimaging international collaborative study
NIMH(PI):The New Tics Study: A Novel Approach to Pathophysiology and Cause of Tic Disorders
NIDDK(Significant Contributor): Brain health across the metabolic continuum in youth at risk for T2D
NIMH(Significant Contributor):Longitudinal Study of Brain Imaging and Cognitive Markers of Tourette Syndrome in Children
Emalex Biosciences(site PI):A Multicenter, Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Ecopipam Tablets in Children and Adolescent Subjects with Tourette’s Syndrome (EBS-101-CL-001)